Genomic Study Maps Shared Risk Factors for 14 Psychiatric Disorders
December 14, 2025
Free CME credits
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
Brand Name :
Imunovir
Synonyms :
inosine pranobex
Class :
Antiviral Agent
Brand Name :
Imunovir
Synonyms :
inosine pranobex
Class :
Antiviral Agent
Dosage Forms & Strengths
Tablet
500 mg
Take daily dose of 50 mg/kg orally in 3 to 4 equally divided doses
Maximum daily dose not more than 3 g
Dosage Forms & Strengths
Tablet
500 mg
Take daily dose of 50 mg/kg orally in 3 to 4 equally divided doses
Maximum daily dose not more than 3 g
Refer to adult dosing
acemetacin may reduce the excretion rate of inosine pranobex, potentially causing a higher serum level
acetaminophen may lower the excretion rate of inosine pranobex, potentially resulting in a higher serum level
Actions and Spectrum
inosine pranobex has antiviral properties and it is effective against different types of viruses, including RNA and DNA viruses.
Frequency not defined
Nervousness
Pruritus
Skin rash
Hyperuricemia
Headache
Insomnia
Dizziness
Arthralgia
Diarrhea
Gastric distress
Fatigue
Increased urine output
Black Box Warning
None
Contraindication/Caution:
Contraindication:
None
Caution:
Pregnancy consideration:
Pregnancy category: N/A
Lactation: Excretion into human milk is unknown
Pregnancy Categories:
Category A: well-controlled and Satisfactory studies show no risk to the fetus in the first or later trimester.
Category B: there was no evidence of risk to the fetus in animal studies, and there were not enough studies on pregnant women.
Category C: there was evidence of risk of adverse effects in animal reproduction studies, and no adequate evidence in human studies must take care of potential risks in pregnant women.
Category D: adequate data with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.
Category X: Drugs listed in this category outweigh the risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.
Category N: There is no data available for the drug under this category.
Pharmacology
inosine pranobex increases the host’s natural antiviral defense mechanisms, primarily by stimulating the production of interferons including interferon-alpha and interferon-gamma.
Pharmacodynamics
inosine pranobex promotes the activation and proliferation of various immune cells, such as T lymphocytes and natural killer (NK) cells. These cells are involved in recognizing and eliminating infected cells.
Pharmacokinetics
Absorption
inosine pranobex is absorbed from the gastrointestinal tract into the bloodstream.
Distribution
inosine pranobex is distributed throughout the body, including different tissues and organs.
Metabolism
inosine pranobex undergoes minimal metabolism in the liver.
Elimination and excretion
The elimination of inosine pranobex occurs primarily occurs through renal excretion.
Administration
inosine pranobex is typically administered orally, and it is available in tables form.
Patient information leaflet
Generic Name: inosine pranobex
Why do we use inosine pranobex?
inosine pranobex is used to treat certain viral infections, including influenza, Herpes Simplex Virus (HSV), Human Papillomavirus (HPV). inosine pranobex is used in the treatment of slowly progressive subacute sclerosing panencephalitis (PSSP) and due to this delay in neurologic deterioration and prolong life expectancy.
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
On course completion, you will receive a full-sized presentation quality digital certificate.
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
